Entacapone/levodopa/carbidopa/rasagilineLack of efficacy: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-024-67385-0
中图分类号
学科分类号
摘要
引用
收藏
页码:196 / 196
相关论文
共 50 条
  • [31] Comparison of 200 mg retarded release levodopa/carbidopa – with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson’s disease
    T. Müller
    L. Ander
    K. Kolf
    D. Woitalla
    S. Muhlack
    Journal of Neural Transmission, 2007, 114 : 1457 - 1462
  • [32] The effect of different dosing regimens of levodopa/carbidopa/entacapone on plasma levodopa concentrations
    Kimmo Ingman
    Tarja Naukkarinen
    Mikko Vahteristo
    Irja Korpela
    Mikko Kuoppamäki
    Juha Ellmén
    European Journal of Clinical Pharmacology, 2012, 68 : 281 - 289
  • [33] Levodopa/carbidopa versus levodopa/carbidopa/entacapone as a predictive factor for the development of motor complications in Parkinson's disease
    Olanow, C. W.
    Kieburtz, K.
    Rascol, O.
    Poewe, W.
    Schapira, A.
    Nissinen, H.
    Leinonen, M.
    Stocchi, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 658 - 658
  • [34] Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease
    Hauser, Robert A.
    Panisset, Michel
    Abbruzzese, Giovanni
    Mancione, Linda
    Dronamraju, Nalina
    Kakarieka, Algirdas
    MOVEMENT DISORDERS, 2009, 24 (04) : 541 - 550
  • [36] The effect of different dosing regimens of levodopa/carbidopa/entacapone on plasma levodopa concentrations
    Ingman, Kimmo
    Naukkarinen, Tarja
    Vahteristo, Mikko
    Korpela, Irja
    Kuoppamaki, Mikko
    Ellmen, Juha
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (03) : 281 - 289